Clinical features of pulmonary arterial hypertension in patients receiving dasatinib. - Wikidata - wikimedia - TriplyDB

Clinical features of pulmonary arterial hypertension in patients receiving dasatinib.

Clinical features of pulmonary arterial hypertension in patients receiving dasatinib.

http://www.wikidata.org/entity/Q38568955

about

Dasatinib for the treatment of chronic myeloid leukemia: patient selection and special considerations Final 5-Year Study Results of DASISION: The Dasatinib Versus Imatinib Study in Treatment-Naïve Chronic Myeloid Leukemia Patients Trial.Pulmonary arterial hypertension due to an intratumoral shunt: an unexpected side effect of sunitinib.Adverse events associated with tyrosine kinase inhibitors for the treatment of chronic myeloid leukemia.Long-Term Side Effects of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia.Second line small molecule therapy options for treating chronic myeloid leukemia.Tyrosine Kinase Inhibitors and Vascular Toxicity: Impetus for a Classification System?In vitro and in vivo evaluation of dasatinib and imatinib on physiological parameters of pulmonary arterial hypertension.Echocardiographic Assessment of Cardiotoxic Effects of Cancer Therapy.Dasatinib: A Review in Chronic Myeloid Leukaemia and Ph+ Acute Lymphoblastic Leukaemia.Hematological disorders and pulmonary hypertension.Protein Quality Control Dysfunction in Cardiovascular Complications Induced by Anti-Cancer Drugs.Drug-induced pulmonary arterial hypertension: a review.Pulmonary Hypertension and Cancer: Etiology, Diagnosis, and Management.Bosutinib induced pleural effusions: Case report and review of tyrosine kinase inhibitors induced pulmonary toxicity.Cardiovascular toxicities of BCR-ABL tyrosine kinase inhibitors in chronic myeloid leukemia: preventive strategies and cardiovascular surveillance.Cardiovascular Complications of Cancer Therapy: Best Practices in Diagnosis, Prevention, and Management: Part 2.Combination targeted pulmonary hypertension therapy in the resolution of Dasatinib-associated pulmonary arterial hypertension.Pleural effusion and molecular response in dasatinib-treated chronic myeloid leukemia patients in a real-life Italian multicenter series.Dasatinib-Induced Pulmonary Arterial Hypertension.Analysis of adverse events associated with dasatinib and nilotinib treatments in chronic-phase chronic myeloid leukemia patients outside clinical trials.Comparative analysis of pulmonary hypertension in patients treated with imatinib, nilotinib and dasatinib.DRUG INDUCED PULMONARY ARTERIAL HYPERTENSION: A PRIMER FOR CLINICIANS AND SCIENTISTS.Dasatinib-Induced Pulmonary Arterial Hypertension Treated with Upfront Combination Therapy.

P2860

Q28079372-7D102601-146B-4299-A42B-3461BA265756 Q37427140-76EC3C77-4B23-45AD-8932-C58AE352CC3C Q38671842-02B9F748-7109-4E7D-9A48-5062FB462859 Q38707841-46EF7648-8CF3-4F9D-B74C-9F14E15DB5E5 Q38753313-E3F1D9DB-CA0C-4926-8A10-AC1578947F97 Q38789049-6E4863B1-B203-4937-84EA-36B9A27C6E0E Q38813467-7F4DB500-5B97-4892-83C7-837D69C0F1AA Q38913950-6959F0B1-B54A-449A-AE85-53B649346B76 Q38938410-BEB8215C-0866-4044-AFAD-8820F9F7C572 Q39061903-35143EBD-4CA2-4CD3-B4C9-50F080E703BB Q39077582-8FD40C2E-9FBF-450D-B6F5-7BC59A2150CB Q39102231-6B658312-A70A-4509-AE3A-EA8BE771640F Q39247400-D16E7DA8-8AA0-424A-B828-0A7ACD0094E0 Q39279796-94A2E1ED-E9EF-4130-8326-C6FD66478C54 Q39339523-8A8D6758-7922-4DBB-A7C7-47BF0A82E8F0 Q41348012-A08612B5-B86E-4314-B8CC-3E3E1BB02556 Q45073137-67FF78AD-78DD-4476-9D06-57BFFFB3B41C Q47168430-9ADC638A-3198-4099-8B9B-1D906CA0F15F Q47877989-6A5FB081-18B8-437A-9723-C40AB325080F Q48243064-CB679E4E-45A5-4732-A41F-EB6B94CFC835 Q48319994-F91ACF97-ADEC-4272-AA12-B874169F0BA4 Q48364277-B495075F-48BF-4C5D-8848-FEC67934320C Q50124360-86F0E647-D3E6-483B-84FE-541068C3AAF8 Q55263553-A1B0F0FD-CB3D-4F85-8A2E-2FCE838A8F2C

P2860

Clinical features of pulmonary arterial hypertension in patients receiving dasatinib.

http://www.wikidata.org/entity/Q38568955

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Clinical features of pulmonary arterial hypertension in patients receiving dasatinib.

@en

type

label

Clinical features of pulmonary arterial hypertension in patients receiving dasatinib.

@en

prefLabel

Clinical features of pulmonary arterial hypertension in patients receiving dasatinib.

@en

P1433

Q38568955-9FD2626F-6D7B-404B-AC02-FE6CA0BD8B1B

P1476

Q38568955-139240A3-D5BC-42A4-85D9-21E9668856D8

P2093

Q38568955-1EC11C56-9D2B-4160-A229-460E8D726561

Q38568955-2EF47239-510E-48D4-9B1D-FE677D5644DD

Q38568955-9340D480-9483-44E5-B4C6-D40CE47FE51F

Q38568955-A487BFDE-CB86-49DD-91E3-B93BD091B833

Q38568955-B2B3BA54-898D-4D13-8ED5-F2B4A3FFBF84

Q38568955-CB199A2B-AE67-4CF8-B2E8-8063ED593945

Q38568955-EE4ED6C5-15B3-4348-9B16-C6D131FA5605

P304

Q38568955-DD350C53-E1D1-4FCB-9235-8D116898E86F

P31

Q38568955-95F22161-92CC-496A-A707-746CCF6827E9

P356

Q38568955-CDE4ED4B-74C0-41B3-B9C6-2544C9A8D74A

P433

Q38568955-0984DFD1-8B5A-4376-8BEB-BF19F4728B7A

P478

Q38568955-2E02334F-6138-4D43-BD1B-B160715358FE

P50

Q38568955-C9E4627E-8250-48E2-AAA3-67C278990E6C

Q38568955-FD27845B-64EF-4C57-9768-7A6A18FC97D3

P577

Q38568955-1B108055-90E5-4B24-827D-05F545D73710

P698

Q38568955-CEE97364-606F-45CF-832B-7B04CCE57842

P356

P1433

American Journal of Hematology

P1476

Clinical features of pulmonary arterial hypertension in patients receiving dasatinib.

@en

P2093

Andrew Peacock

http://www.w3.org/2001/XMLSchema#string

Harrison W Farber

http://www.w3.org/2001/XMLSchema#string

Mausumee Guha

http://www.w3.org/2001/XMLSchema#string

Michael J Mauro

http://www.w3.org/2001/XMLSchema#string

Neil P Shah

http://www.w3.org/2001/XMLSchema#string

Nicola Wallis

http://www.w3.org/2001/XMLSchema#string

Robert A Wolf

http://www.w3.org/2001/XMLSchema#string

P304

1060-1064

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/AJH.24174

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

90

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-08-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26284693

http://www.w3.org/2001/XMLSchema#string